What's happening with the Medibank share price today?

Medibank made a commitment at the start of the pandemic that it would not profit from COVID-19.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price is slightly in the green in early morning trade on Thursday.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $3.50. Shares are currently changing hands for $3.505, up 0.14%.

This comes after Australia's biggest health insurer updated the market on its ongoing COVID-19 support package and give-back program.

excited young female in business attire and wearing glasses is holding up $100 notes in both hands.

Image source: Getty Images

What did the ASX 200 health insurer report?

In an announcement unlikely to have a direct material impact on the Medibank share price today, the health insurer announced it would return another $125 million to its customers.

Medibank has now provided $1.15 billion in support to its customers since the start of the global pandemic in early 2020.

The company said its customers would receive funds directly in their bank accounts. The new round of support will be up to $91 for extras-only policies and up to $402 for hospital and extras policies.

Medibank and ahm customers can expect those funds by October.

The cash return is funded from additional COVID-19 permanent net claims savings. Management said it would not impact the insurer's operating earnings for H1 2023. This is why I don't expect the new round of support funds will drag on the Medicare share price.

Commenting on the support package, group executive Milosh Milisavljevic said, "We have now given back $1.15 billion to customers through our COVID-19 give-back program since the start of the pandemic."

Milisavljevic continued:

This year alone we have returned $408 million to customers through cash backs, premium increase deferrals and rolling over extras limits. At a time when people are really feeling the pinch of cost-of-living pressures, we know this extra cash in their pocket will be welcomed.

We made a commitment at the start of the pandemic that we would not profit from COVID-19, and we've stuck by that promise.

Clients holding an active hospital and/or extras policy at any time during the first half of 2023 will be eligible for some portion of the cash-back package.

Medibank share price snapshot

The Medibank share price has been a strong performer in 2023, up 21% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Broker sees 26% upside in ASX healthcare share behind Chemist Warehouse

Morgans has just upgraded its rating on this ASX healthcare stock due to ongoing share price weakness.

Read more »

Woman using a pen on a digital stock market chart in an office.
Healthcare Shares

Why this ASX healthcare stock is surging while the market sinks on Middle East fears

Avita shares surge as a US government contract boosts sentiment again

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Healthcare Shares

Should you buy Telix shares after its big US news?

Is this milestone a reason to invest? Let's find out.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Up 31% in a month, why are Telix shares lifting off again on Friday?

ASX investors are piling into Telix shares today. But why?

Read more »

Doctor checking patient's spine x-ray image.
Healthcare Shares

Where is the value amongst ASX healthcare shares?

These three stocks are worth monitoring.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Telix Pharmaceuticals: FDA accepts Pixclara NDA

The FDA has accepted Telix's Pixclara NDA for imaging brain cancer.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Bell Potter says this ASX healthcare stock could rise nearly 200%

The positive announcement has reinforced the broker's recommendation.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Healthcare Shares

CSL shares: 3 reasons to buy and 3 reasons to sell

CSL shares have tumbled again.

Read more »